Found: 2
Select item for more details and to access through your institution.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 5, p. 376, doi. 10.1001/jama.2022.25029
- By:
- Publication type:
- Article
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article